Medication info
Vipozi 5/80 mg (Amlodipine Besylate, Valsartan)

Vipozi 5/80 mg (Amlodipine Besylate, Valsartan)

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
Dark yellow round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201603064 · Approved 2016.05.30 · Insurance code 694001130

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using either component, switching directly to this medicine may be considered, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10 mL/min or greater). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10 mL/min) or to patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. ○ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80 mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. ○ Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
Child dose
○ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; administration of this drug is not recommended.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension whose blood pressure control is insufficient with monotherapy of amlodipine or valsartan.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using either component, switching directly to this medicine may be considered, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10 mL/min or greater). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10 mL/min) or to patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. ○ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80 mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. ○ Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.

Child dose

○ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; administration of this drug is not recommended.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Patients with an allergy to the active ingredients, pregnant or breastfeeding women, patients with severe kidney or liver disease, and those with certain heart diseases should not use this medication. Patients with low sodium or fluid may experience hypotension, so they should carefully assess their condition before taking the medication and monitor blood pressure and symptoms closely while taking it. Patients with high potassium levels may face risks when taking this medication with potassium supplements, so blood potassium levels should be checked frequently. Patients with kidney issues or kidney transplant recipients need caution as kidney function may worsen when taking this medication. If angioedema occurs, the medication should be discontinued immediately and not readministered. Patients with heart failure or myocardial infarction must closely monitor their kidney function when taking this medication, as symptoms such as pulmonary edema may occur. Patients with acute myocardial infarction or certain heart valve diseases also require special caution during use. This medication can increase the risks of hypotension, worsening kidney function, and hyperkalemia when used with other antihypertensives, so blood pressure and blood tests should be performed frequently under the direction of a physician. Dizziness or fatigue may occur when driving or operating machinery, so caution is advised. In case of overdose, hypotension or cardiac function deterioration may occur, requiring immediate medical treatment. This medication is not recommended for patients under 18 years of age as its safety and efficacy have not been sufficiently established. In elderly patients, a similar dosage to that of general adults is recommended, but physical condition should be closely monitored. Regular monitoring of liver function, kidney function, blood pressure, and electrolyte levels is important during treatment. This medication may interact with certain drugs, so anyone taking other medications should consult their doctor or pharmacist. Pregnant women, women planning a pregnancy, and breastfeeding women should avoid this medication; if pregnancy is confirmed during treatment, it must be discontinued immediately.

Side effects

Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint edema, low back pain, arthritis, muscle cramps, weakness, polyuria, nocturia, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, vesicular dermatitis, myalgia, renal failure, kidney injury, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, decreased sensation, dysgeusia, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, phototoxic reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, dysuria, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux, neck pain, hypercholesterolemia, hypoglycemia, nervousness, decreased sensation, Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air or moisture, at a temperature between 1 to 30 degrees Celsius (room temperature). By doing so, the efficacy of the medication can be maintained for a longer period.

Appearance and packaging

Appearance

Dark yellow round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.